Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
20.90
+0.60 (2.96%)
At close: Mar 27, 2026
Market Cap9.55B
Revenue (ttm)146.34M
Net Income-379.87M
EPS-0.88
Shares Out456.82M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume886,600
Average Volume864,040
Open20.30
Previous Close20.30
Day's Range20.30 - 22.30
52-Week Range19.05 - 74.00
Betan/a
RSI37.10
Earnings DateMar 23, 2026

About HKG:2591

Guangzhou Innogen Pharmaceutical Group Co., Ltd engages in the development of drugs. The company’s products are used for the treatment of metabolic diseases, including diabetes, obesity, and MASH; and other major central nervous system diseases. The company was incorporated in 2014 and is based in Shanghai, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 105
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2591
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements